Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3006

Actual shortage: 230 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2747 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2023-04-27 185927
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-08 2024-03-15 221717
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-05-28 2021-08-03 140066
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-10-22 2021-10-29 147806
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-09-16 2022-10-07 169519
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-11-11 2022-12-05 174343
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2023-03-09 2023-04-21 186572
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 2G 0.25G POWDER FOR SOLUTION Actual shortage 2017-03-11 2018-09-12 583
CEFEPIME FOR INJECTION 2G POWDER FOR SOLUTION Actual shortage 2017-03-12 2017-10-05 698
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2019-07-31 2019-08-02 90341
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2019-12-05 2020-02-18 100265
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2021-06-11 2021-08-06 140772
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2021-09-17 2021-10-25 145822
APO-CEFEPIME 2G POWDER FOR SOLUTION Resolved 2024-02-23 2024-03-01 220444
APO-LOPERAMIDE 2MG TABLET Actual shortage 2017-03-10 2017-10-05 372
APO-TOLTERODINE 2MG TABLET Resolved 2017-03-11 2017-11-07 519
APO-TOLTERODINE 2MG TABLET Resolved 2017-03-11 2018-02-28 523

Showing 1641 to 1660 of 3006

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71032
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71035
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71038
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71044
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71048
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71051
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71057
ACID CONTROL Discontinued 2019-01-04 2019-01-04 71198
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO PEN VK Discontinued 2019-03-08 2019-03-08 78141
APO PEN VK Discontinued 2019-03-08 2019-03-08 78144
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83971
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83976
APO-AMOXI CLAV 250MG/62.5MG PER 5ML Discontinued 2019-05-13 2019-05-13 83981
APO-AMOXI CLAV Discontinued 2019-05-17 2019-05-18 84392
APO-CEFPROZIL Discontinued 2019-05-17 2019-05-18 84396
APO-CEFPROZIL Discontinued 2019-06-12 2019-06-12 86542
APO-CIPROFLOX Discontinued 2019-06-12 2019-06-12 86547
APO-EXEMESTANE Discontinued 2019-06-12 2019-06-12 86552
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557

Showing 21 to 40 of 356